Join our group to develop an innovative immunotherapy platform of bispecific \Immune Cell Recruiters\ (ICRs) to reprogram tumor vasculature and boost immune infiltration in a 3‑year funded position. A continuación se detalla todo lo que necesita
Join our group to develop an innovative immunotherapy platform of bispecific\ Immune Cell Recruiters\ (ICRs) to reprogram tumor vasculature and boost immune infiltration in a 3‑year funded position. A continuación se detalla todo lo que necesita